Excedrin and Obs - a phase IV clinical study of FDA data
Summary:
We study 23,037 people who take Excedrin (acetaminophen; aspirin; caffeine) or have Obs. No report of Obs is found in people who take Excedrin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Excedrin?
Excedrin has active ingredients of acetaminophen; aspirin; caffeine. It is often used in headache. eHealthMe is studying from 22,739 Excedrin users. Check the latest studies of Excedrin.
What is Obs?
Obs is found to be associated with 36 drugs and 226 conditions by eHealthMe. Check the latest studies of Obs.
No report is found.
Do you take Excedrin and have Obs?
- Check whether Obs is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Excedrin:
- Excedrin (22,739 reports)
Obs treatments and more:
- Obs (298 reports)
How severe was Obs and when was it recovered:
Expand to all the drugs that have ingredients of acetaminophen; aspirin; caffeine:
Browse all side effects of Excedrin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Obs:
Browse all the conditions that are associated with Obs:
Drugs similar to Excedrin and Obs :
How the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; aspirin; caffeine (the active ingredients of Excedrin) and Excedrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Magnesium Glycinate and Coenzyme Q10 drug interactions for women aged 60+ - 21 seconds ago
- Nail Abnormalities and drugs of ingredients of bevacizumab - 32 seconds ago
- Drug interactions of Iodine and Restasis - 48 seconds ago
- Levemir and Hypoglycemia for Men aged 50-59 - 51 seconds ago
- Levemir and Low Blood Sugar for Men aged 50-59 - 51 seconds ago
- Levemir and Insulin Shock for Men aged 50-59 - 51 seconds ago
- Levemir and Hypoglycaemia for Men aged 50-59 - 52 seconds ago
- Could Simethicone cause Skin Exfoliation? - 53 seconds ago
- Could Zyrtec cause Retinal Detachment? - a minute ago
- Carvedilol and Tradjenta drug interactions for women aged 40-49 - a minute ago